148 related articles for article (PubMed ID: 12849327)
21. Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants.
Sawle GV; Bloomfield PM; Björklund A; Brooks DJ; Brundin P; Leenders KL; Lindvall O; Marsden CD; Rehncrona S; Widner H
Ann Neurol; 1992 Feb; 31(2):166-73. PubMed ID: 1575455
[TBL] [Abstract][Full Text] [Related]
22. Ethical challenges in cell-based interventions for neurological conditions: some lessons to be learnt from clinical transplantation trials in patients with Parkinson's disease.
Hildt E
Am J Bioeth; 2009 May; 9(5):37-8. PubMed ID: 19396682
[No Abstract] [Full Text] [Related]
23. Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients.
Levivier M; Dethy S; Rodesch F; Peschanski M; Vandesteene A; David P; Wikler D; Goldman S; Claes T; Biver F; Liesnard C; Goldman M; Hildebrand J; Brotchi J
Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):99-111. PubMed ID: 9711741
[TBL] [Abstract][Full Text] [Related]
24. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study.
Ma Y; Feigin A; Dhawan V; Fukuda M; Shi Q; Greene P; Breeze R; Fahn S; Freed C; Eidelberg D
Ann Neurol; 2002 Nov; 52(5):628-34. PubMed ID: 12402261
[TBL] [Abstract][Full Text] [Related]
25. Neural transplantation in Parkinson's disease: the Swedish experience.
Lindvall O; Rehncrona S; Brundin P; Gustavii B; Astedt B; Widner H; Lindholm T; Björklund A; Leenders KL; Rothwell JC
Prog Brain Res; 1990; 82():729-34. PubMed ID: 2290977
[No Abstract] [Full Text] [Related]
26. Development of fetal neural transplantation as a treatment for Parkinson's disease.
Clarkson ED; Freed CR
Life Sci; 1999 Oct; 65(23):2427-37. PubMed ID: 10622227
[TBL] [Abstract][Full Text] [Related]
27. Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next?
Politis M
BMC Med; 2010 Dec; 8():80. PubMed ID: 21126348
[TBL] [Abstract][Full Text] [Related]
28. [18F]-6-L-fluorodopa PET studies of graft and host dopaminergic function following fetal mesencephalic transplantation.
Sawle GV
Adv Neurol; 1993; 60():715-20. PubMed ID: 8420216
[No Abstract] [Full Text] [Related]
29. Are dyskinesias a problem after neural transplantation for Parkinson's disease?
Bradbury J
Lancet; 2002 Jun; 359(9322):2007. PubMed ID: 12076564
[No Abstract] [Full Text] [Related]
30. The effect of neurotrophin-5 on the growth and survival of nigral grafts in a rat model of Parkinson's disease.
Haque NS; Hlavin ML; Fawcett J; Dunnett SB
Gene Ther; 1994; 1 Suppl 1():S60. PubMed ID: 8542406
[No Abstract] [Full Text] [Related]
31. Parkinson's research. Fetal cell transplant trial draws fire.
Vogel G
Science; 2001 Mar; 291(5511):2060-1. PubMed ID: 11256388
[No Abstract] [Full Text] [Related]
32. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon.
Peschanski M; Defer G; N'Guyen JP; Ricolfi F; Monfort JC; Remy P; Geny C; Samson Y; Hantraye P; Jeny R
Brain; 1994 Jun; 117 ( Pt 3)():487-99. PubMed ID: 8032859
[TBL] [Abstract][Full Text] [Related]
33. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants.
Politis M; Wu K; Loane C; Quinn NP; Brooks DJ; Rehncrona S; Bjorklund A; Lindvall O; Piccini P
Sci Transl Med; 2010 Jun; 2(38):38ra46. PubMed ID: 20592420
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases.
Mendez I; Dagher A; Hong M; Gaudet P; Weerasinghe S; McAlister V; King D; Desrosiers J; Darvesh S; Acorn T; Robertson H
J Neurosurg; 2002 Mar; 96(3):589-96. PubMed ID: 11883846
[TBL] [Abstract][Full Text] [Related]
35. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease.
Brundin P; Pogarell O; Hagell P; Piccini P; Widner H; Schrag A; Kupsch A; Crabb L; Odin P; Gustavii B; Björklund A; Brooks DJ; Marsden CD; Oertel WH; Quinn NP; Rehncrona S; Lindvall O
Brain; 2000 Jul; 123 ( Pt 7)():1380-90. PubMed ID: 10869050
[TBL] [Abstract][Full Text] [Related]
36. Benefits and risks of hosting animal cells in the human brain.
Isacson O; Breakefield XO
Nat Med; 1997 Sep; 3(9):964-9. PubMed ID: 9288721
[No Abstract] [Full Text] [Related]
37. Unilateral fetal mesencephalic grafting in two patients with Parkinson's disease: short-term result after transplantation.
Chung CK; Kim HJ; Jeon BS; Kim YS; Lee SB; Han DH
No Shinkei Geka; 1996 Nov; 24(11):987-93. PubMed ID: 8934466
[TBL] [Abstract][Full Text] [Related]
38. Assessment of fetal tissue transplantation in Parkinson's disease: does PET play a role?
Martin WR; Perlmutter JS
Neurology; 1994 Oct; 44(10):1777-80. PubMed ID: 7936219
[No Abstract] [Full Text] [Related]
39. Stereotactic implantation of fetal mesencephalon.
Hitchcock ER; Kenny BG; Clough CG; Hughes RC; Henderson BT; Detta A
Stereotact Funct Neurosurg; 1990; 54-55():282-9. PubMed ID: 2080343
[TBL] [Abstract][Full Text] [Related]
40. Fetal grafts for Parkinson's disease: Decades in the making.
Kordower JH; Olanow CW
Proc Natl Acad Sci U S A; 2016 Jun; 113(23):6332-4. PubMed ID: 27247420
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
